CN Patent

CN102724967A — 包括可释放的脲连接体的含芳香胺化合物的聚合缀合物

Assigned to Enzon Pharmaceuticals Inc · Expires 2012-10-10 · 14y expired

What this patent protects

本发明涉及包括含胺化合物和生物活性剂的可释放的脲连接体系。尤其是，本发明涉及基于分子内环化辅助的可释放的脲连接到含芳香胺的化合物的可逆释放的连接体，本发明也涉及基于吲哚酮的酪氨酸激酶抑制剂的聚合缀合物。

USPTO Abstract

本发明涉及包括含胺化合物和生物活性剂的可释放的脲连接体系。尤其是，本发明涉及基于分子内环化辅助的可释放的脲连接到含芳香胺的化合物的可逆释放的连接体，本发明也涉及基于吲哚酮的酪氨酸激酶抑制剂的聚合缀合物。

Drugs covered by this patent

Patent Metadata

Patent number: CN102724967A
Jurisdiction: CN
Classification: —
Expires: 2012-10-10
Drug substance claim: No
Drug product claim: No
Assignee: Enzon Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.